usci has gathered professional and outstanding experienced elites with the ambition of promoting gene technology and innovation. from the company has created, usci has formed mature operation mode and great market distribution channel. besides, usci has advanced clinical and molecular test and gene sequencing laboratories and is equipped with the world-class gene sequencing hardware with supporting biological information analysis capacity. including nextseq 500 and hiseq 4000 high-throughput sequencing and self-developed bioinformatics analysis platform. usci is also well versed with processing large-scale samples ,and big data mining and analysis. thus, usci takes the lead in chinese gene technology research and gene product development. usci has gathered top-class international and domestic experts in genomics and clinical medicine. the core team composed of multidisciplinary talents in life sciences, clinical medicine, bioinformatics, computer science, physics and statistics can provide modern medicine health solution which integrates prevention, forecast, detection, interpretation and intervention of diseases.
currently, usci focuses on large-scale birth defect detection and tumor precision medical. by independently developing and forming a series of featured products and services, usci has successfully built all-round integration test service technology platform. our business has covered nearly 20 provinces across china. in the meantime, usci strive to improve service capability, expanded overseas and domestic business, expecting to satisfy increasing demands - for new-type clinical test services.
usci has obtained the qualification of third party clinical laboratory certified by national health and family planning commission of the prc; the approval of gene expansion laboratory; qualified unit of “2015 national tumor diagnosis and treatment high-throughput sequencing quality evaluation”. besides, usci is the high-tech enterprise in zhongguancun and scientific cooperative unit of cancer foundation of china.
usci aim to promote precision medicine mainly in oncology as well as in reproductive health. by mining big genetic data and establishing the association between genetics and clinical relevance. we hope our research can be eventually translated to a basic tool for clinical diagnosis and used to assist physician to make treatment decision. with rapid development of ngs technology, we believe that more and more people will experience using a securer, more accurate, convenient and economical clinical diagnostic test.
| add： | building c7, yiyuan creative industry park, no.65 xingshikou rd, haidian, beijing. |
| tel： | 4006-881-555 |
| email： | service@scisoon.cn |
| web： | www.scisoon.cn |
| tel： | 010-62673635-8222; 010-62730266 |
| email： | partnership@scisoon.cn |
| tel： | 010-62730655 |
| email： | hr@scisoon.cn |
| tel： | 010-62730655 |
| email： | kf@scisoon.cn |